Stock Comparison

HLN vs NBIX

Haleon plc and Neurocrine Biosciences Inc side by side — valuation, profitability, growth and risk.

HLN

Haleon plc

Healthcare

NBIX

Neurocrine Biosciences Inc

Healthcare

Valuation

Market Cap

$40.72B

$16.94B

P/E (TTM)

18.9

25.9

Forward P/E

17.5

23.2

Price/Sales

3.7

5.5

Price/Book

1.9

4.9

EV/EBITDA

13.3

18.8

Dividend Yield

2.09%

—

Profitability

Net Margin

15.10%

21.50%

Operating Margin

23.20%

22.80%

Return on Equity

10.30%

22.50%

Return on Assets

4.67%

11.60%

Growth (YoY)

Revenue Growth

0.60%

42.20%

Earnings Growth

92.00%

2311.00%

Price & Risk

Beta

0.2

0.4

52-Week High

$11.13

$169.57

52-Week Low

$8.60

$122.14

Analyst Target

$11.69

$194.38

Compare HLN and NBIX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.